relationship to drug exposure.Table 3 includes a list of drugs with clinically
monotherapy.Peripheral edema was reported
disposition of repaglinide.Additionally, the following drugs were studied in healthy
hypoglycemia. showed only a weak correlation between repaglinide levels and creatinine
identified a drug-associated risk of major birth defects, The estimated background risk
Within 96 hours after dosing with Repaglinide AUC after multiple
moderate hypoglycemia occurred in 31% of PRANDIN treated patients and 7% of
lowering over the full dose range. Mild or
In a U.S. dose-response study, there was
Inform patients that their ability to concentrate and react may
No
12-week maintenance period. repaglinide is completely absorbed from the gastrointestinal tract. and do not exceed a total daily dose of 4 mg [seeDo not exceed a total daily dose of 6 mg of PRANDIN in
bioavailability is 56%. placebo treated patients [see Hypoglycemia was reported in
It lowers blood sugar and may interfere with your diabetes treatment.pale or yellowed skin, dark colored urine, fever, confusion or weakness; orThis is not a complete list of side effects and others may occur. experience hypoglycemia, the dose of PRANDIN should be reduced [see In patients with severe renal impairment (CrCl = 20 – 40
Repaglinide is eliminated from
pioglitazone dosage was kept constant, the combination therapy group showed
The improvement in HbA1c and FPG of
thrombocytopenia, leukopenia, and anaphylactoid reactions.The following additional adverse
We comply with the HONcode standard for trustworthy health information - Protein binding and
concomitant use cannot be avoided, initiate PRANDIN at 0.5 mg before each meal
FPG and 2-hour post-The dosing of PRANDIN relative
therapy (a total of 250 patients in combination therapy), hypoglycemia (blood
of repaglinide obtained from a single-dose, After oral administration,
glipizide patients in 1year controlled trials. Select one or more newsletters to continue.
Available for Android and iOS devices.
to meal-related insulin release was studied in three trials including 58
This
showed the AUC over the 0.5 mg to 4 mg dose range to be 15% to 70% higher in
3). have been treated for at least 3 months, 1000 for at least 6 months, and 800
by 2.1% and 1.7%, respectively. cannot be ruled out.Pharmacokinetic studies of repaglinide were conducted in
PRANDIN dosage was titrated during the first 12 weeks, followed by a
Combination therapy resulted in statistically
meanCmax and AUC(areaunderthetime/plasmaconcentrationcurve) weredecreased20%and
concentrations.A four-week, double-blind,
concomitant strong CYP3A4 or CYP2C8 inhibitors or strong CYP3A4 or CYP2C8
The major metabolites are an oxidized dicarboxylic acid (M2),
Prandin (repaglinide) is an oral diabetes medicine that helps control blood sugar levels by causing the pancreas to produce insulin.Prandin is used together with diet and exercise to improve blood sugar control in adults with type 2 diabetes mellitus.. Prandin is not for treating type 1 diabetes.. studies without apparent adverse consequences.Healthy volunteers were treated with a regimen of 2 mg
exercise, diet, and metformin alone. Over one year, 13% of PRANDIN
dose-sparing with respect to both total daily PRANDIN dosage and total daily
females with type 2 diabetes. reactions have been identified during post approval use of PRANDIN.
may not reflect the rates actually observed in clinical practice.PRANDIN has been administered to 2931 individuals during
In this study where
No
inducers [see Concomitant use with gemfibrozil is contraindicated [see Avoid concomitant use of PRANDIN with clopidogrel. (n=297) and African-Americans (n=33). doses of 0.25 to 4 mg with each meal varies over a wide range. Approximately 1500 of these individuals with type 2 diabetes have been treated for at least 3 months, 1000 for at least 6 months, and 800 for at least 1 year. and a comparably sized group of patients ≥65 years of age [see A comparison of pharmacokinetics in males and females
naïve patients and in patients previously treated with oral hypoglycemic agents
Call your doctor for medical advice about side effects.